Myanmar vs Vanuatu: Death rate from Alzheimer's
Myanmar
8.36 deaths per 100,000 people
in 2021
Vanuatu
8.51 deaths per 100,000 people
in 2021
Myanmar rank
103rd
Vanuatu rank
101st
Death rate from Alzheimer's over time
- Myanmar
- Vanuatu
How they compare
Vanuatu currently reports 8.51 deaths per 100,000 people against 8.36 deaths per 100,000 people in Myanmar, a difference of 0.15 deaths per 100,000 people.
Across all 22 years both countries report, Vanuatu has been ahead every year.
Myanmar ranks 103rd and Vanuatu ranks 101st of 194 countries.
Vanuatu has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.11 deaths per 100,000 people | 9.64 deaths per 100,000 people | 3.53 deaths per 100,000 people | Vanuatu |
| 2010s | 7.52 deaths per 100,000 people | 10.02 deaths per 100,000 people | 2.5 deaths per 100,000 people | Vanuatu |
| 2020s | 8.54 deaths per 100,000 people | 8.89 deaths per 100,000 people | 0.35 deaths per 100,000 people | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Myanmar or Vanuatu?
- Vanuatu, at 8.51 deaths per 100,000 people against 8.36 deaths per 100,000 people in Myanmar as of 2021.
- What is the difference in death rate from alzheimer's between Myanmar and Vanuatu?
- 0.15 deaths per 100,000 people, with Vanuatu ahead.
- How many years of comparable data are there for Myanmar and Vanuatu?
- 22 years are reported by both, from 2000 to 2021.
- How do Myanmar and Vanuatu rank globally for death rate from alzheimer's?
- Myanmar ranks 103rd and Vanuatu ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.